Results
Aurobindo Pharma Q1FY27 Revenue Up 16.3% YoY
Aurobindo Pharma reported Q1FY27 revenue of ₹9,150 Cr, a 16.3% YoY growth, with Operating EBITDA at ₹1,924 Cr (21.0% margin).
Net Profit rose 25.2% YoY to ₹1,033 Cr; the company launched 10 products i
